Omadacycline Treatment of Severe Pneumonia Complicated with ARDS During COVID-19

frontiersin.org
omadacycline-treatment-of-severe-pneumonia-complicated-with-ards-during-covid-19

Metagenomic next-generation sequencing (mNGS) has a significant value in the diagnosis of Chlamydia psittaci infection. Timely treatment of omadacycline can improve prognosis and provide a promising new option for the treatment of severe Chlamydia psittaci pneumonia with ARDS.

Common symptoms included fever, dyspnea, and cough. All patients developed ARDS, accompanied by septic shock (43.7%) and pulmonary embolism (43.7%).

Laboratory data showed normal leucocytes, increased creatine kinase isoenzyme, and decreased albumin with liver dysfunction in most patients. All patients had increased neutrophils, C-reactive protein, procalcitonin, and D-dimer with decreased lymphocytes. Airspace consolidation, ground glass opacity, and pleural effusion were found on chest CT.

mNGS results were obtained in 24–48 h to identify the diagnosis of Chlamydia psittacosis.

All patients received mechanical ventilation with omadacycline treatment.

Fourteen patients experienced complete recovery, while the other two patients died from multidrug-resistant bacterial infection and renal failure.

Read More